HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $336 | 0.0% | 289,269 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $336 | -23.1% | 289,269 | 0.0% | 0.00% | -50.0% |
Q1 2023 | $437 | -64.2% | 289,269 | 0.0% | 0.00% | -66.7% |
Q4 2022 | $1,221 | -99.9% | 289,269 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $1,221,000 | -29.7% | 289,269 | -53.5% | 0.01% | -33.3% |
Q2 2022 | $1,736,000 | -36.2% | 622,233 | +30.8% | 0.01% | -10.0% |
Q1 2022 | $2,721,000 | -37.3% | 475,633 | 0.0% | 0.01% | -28.6% |
Q4 2021 | $4,343,000 | -10.1% | 475,633 | +5.2% | 0.01% | -22.2% |
Q3 2021 | $4,833,000 | +48230.0% | 452,150 | +82109.1% | 0.02% | – |
Q3 2019 | $10,000 | +42.9% | 550 | +37.5% | 0.00% | – |
Q2 2019 | $7,000 | -30.0% | 400 | 0.0% | 0.00% | – |
Q1 2019 | $10,000 | 0.0% | 400 | 0.0% | 0.00% | – |
Q4 2018 | $10,000 | -37.5% | 400 | -20.0% | 0.00% | – |
Q3 2018 | $16,000 | -15.8% | 500 | 0.0% | 0.00% | – |
Q2 2018 | $19,000 | +35.7% | 500 | 0.0% | 0.00% | – |
Q1 2018 | $14,000 | +55.6% | 500 | 0.0% | 0.00% | – |
Q4 2017 | $9,000 | – | 500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |